600196
vs
JNJ
600196
JNJ
Over the past 12 months, Shanghai Fosun Pharmaceutical Group Co Ltd has underperformed JNJ, delivering a return of +6% compared to the JNJ's +43% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
600196
JNJ
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
Intrinsic Value
34.4
CNY
Undervaluation 25%
JNJ
Intrinsic Value
172.09
USD
Overvaluation 24%
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
|
25.87
CNY
|
|||||
|
Johnson & Johnson
NYSE:JNJ
|
225.49
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
600196, JNJ
600196, JNJ
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Shanghai Fosun Pharmaceutical Group Co Ltd
Revenue
|
|||||||||||
|
|
Johnson & Johnson
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
600196, JNJ
600196, JNJ
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
|
|||||||||
|
|
Johnson & Johnson
NYSE:JNJ
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Shanghai Fosun Pharmaceutical Group Co Ltd
49.9%
JNJ
67.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Shanghai Fosun Pharmaceutical Group Co Ltd | ||||
|
|
Johnson & Johnson | ||||
Operating Margin
Shanghai Fosun Pharmaceutical Group Co Ltd
7.2%
JNJ
27.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Shanghai Fosun Pharmaceutical Group Co Ltd | ||||
|
|
Johnson & Johnson | ||||
Net Margin
Shanghai Fosun Pharmaceutical Group Co Ltd
8.1%
JNJ
21.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Shanghai Fosun Pharmaceutical Group Co Ltd | ||||
|
|
Johnson & Johnson | ||||
FCF Margin
Shanghai Fosun Pharmaceutical Group Co Ltd
1.8%
JNJ
20.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Shanghai Fosun Pharmaceutical Group Co Ltd | ||||
|
|
Johnson & Johnson | ||||
ROE
Shanghai Fosun Pharmaceutical Group Co Ltd
7%
JNJ
27.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Shanghai Fosun Pharmaceutical Group Co Ltd | ||||
|
|
Johnson & Johnson | ||||
ROA
Shanghai Fosun Pharmaceutical Group Co Ltd
2.8%
JNJ
11.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Shanghai Fosun Pharmaceutical Group Co Ltd | ||||
|
|
Johnson & Johnson | ||||
ROIC
Shanghai Fosun Pharmaceutical Group Co Ltd
2.5%
JNJ
14.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Shanghai Fosun Pharmaceutical Group Co Ltd | ||||
|
|
Johnson & Johnson | ||||
ROCE
Shanghai Fosun Pharmaceutical Group Co Ltd
3.7%
JNJ
19.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Shanghai Fosun Pharmaceutical Group Co Ltd | ||||
|
|
Johnson & Johnson | ||||
Solvency Comparison
Shanghai Fosun Pharmaceutical Gr...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
600196, JNJ
600196, JNJ
Performance By Year
600196, JNJ
600196, JNJ
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 600196 to other stocks
LLY
Eli Lilly and Co
More expensive
vs Shanghai Fosun Pharmaceutical...
ROG
Roche Holding AG
More expensive
vs Shanghai Fosun Pharmaceutical...
AZN
AstraZeneca PLC
More expensive
vs Shanghai Fosun Pharmaceutical...
NOVN
Novartis AG
More expensive
vs Shanghai Fosun Pharmaceutical...
Select Stock to Compare
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
